Search Results for: BBS4

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PCM1 pericentriolar material 1
  • Regulation of PLK1 Activity at G2/M Transition
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Anchoring of the basal body to the plasma membrane
  • AURKA Activation by TPX2
RARA retinoic acid receptor alpha
  • Nuclear Receptor transcription pathway
  • SUMOylation of intracellular receptors
  • Signaling by Retinoic Acid
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • Transcriptional regulation of granulopoiesis
  • Transcriptional regulation of granulopoiesis
  • Adapalene
  • Acitretin
  • Alitretinoin
  • Tretinoin
  • Tazarotene
  • Etretinate
  • Isotretinoin
  • Tamibarotene
  • LGD-1550
  • Trifarotene
  • Isolated orofacial clefts, including: Cleft lip with or without cleft palate; Cleft palate
  • Acute myeloid leukemia (AML)
RARG retinoic acid receptor gamma
  • Nuclear Receptor transcription pathway
  • Signaling by Retinoic Acid
  • Activation of anterior HOX genes in hindbrain development during early embryogenesis
  • Adapalene
  • Acitretin
  • Alitretinoin
  • Tretinoin
  • Tazarotene
  • Etretinate
  • Isotretinoin
  • SR11254
  • BMS-181156
  • CD564
  • Dodecyl-Alpha-D-Maltoside
  • BMS184394
  • R667
  • LGD-1550
  • 3-Fluoro-4-{[(2R)-2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)acetyl]amino}benzoic acid
  • 3-fluoro-4-[2-hydroxy-2-(5,5,8,8-tetramethyl-5,6,7,8,-tetrahydro-naphtalen-2-yl)-acetylamino]-benzoic acid
  • Trifarotene
REL REL proto-oncogene, NF-kB subunit
  • Activation of NF-kappaB in B cells
  • Hodgkin lymphoma
SPIRE1 spire type actin nucleation factor 1
ZIC1 Zic family member 1

Page 2 out of 2 pages